These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2184124

  • 21. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM.
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [Abstract] [Full Text] [Related]

  • 22. An etiologic approach to management of duodenal and gastric ulcers.
    Rex DK.
    J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
    [Abstract] [Full Text] [Related]

  • 23. The pathophysiological and pharmacological basis of peptic ulcer therapy.
    Freston JW.
    Toxicol Pathol; 1988 Jan; 16(2):260-6. PubMed ID: 2903542
    [Abstract] [Full Text] [Related]

  • 24. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H.
    Hepatogastroenterology; 2004 Jan; 51(56):338-42. PubMed ID: 15086153
    [Abstract] [Full Text] [Related]

  • 25. [Drug therapy of peptic ulcer. What is coming up?].
    Müller P, Dammann HG, Simon B, Kommerell B.
    Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707
    [Abstract] [Full Text] [Related]

  • 26. Peptic ulcers in the elderly: unique features and management.
    Freston MS, Freston JW.
    Geriatrics; 1990 Jan; 45(1):39-42, 45. PubMed ID: 2403956
    [Abstract] [Full Text] [Related]

  • 27. The gastric acid conundrum in peptic ulcer.
    Dobrilla G, Steele A, Comberlato M, Amplatz S.
    Ital J Gastroenterol; 1990 Jun; 22(3):142-6. PubMed ID: 2131944
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The limitations of current therapy in peptic ulcer disease.
    Salena BJ, Hunt RH.
    Clin Invest Med; 1987 May; 10(3):171-7. PubMed ID: 3304747
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Drug therapy of peptic ulcer disease.
    Ching CK, Lam SK.
    Br J Hosp Med; 1987 May; 54(2-3):101-6. PubMed ID: 7551483
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inhibition of gastric acid secretion and therapeutic results: is there any correlation?
    Corinaldesi R, Ghidini C, Ricci Maccarini M, Santaguida P, Fratesi E, Barbara G, Stanghellini V.
    Ital J Gastroenterol; 1990 May; 22 Suppl 1():2-4. PubMed ID: 1983421
    [Abstract] [Full Text] [Related]

  • 36. Powerful gastric acid inhibition: when is it justified?
    Dobrilla G, Amplatz S.
    Ital J Gastroenterol; 1990 May; 22 Suppl 1():13-7. PubMed ID: 1983420
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 May; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.